We discovered that under diabetic conditions, RasGRP4 can — by influencing the infiltration of renal immune cells — regulate the interaction between mononuclear cells and glomerular vascular endothelial cells, thereby giving rise to the pathogenesis and advancement of DKD (19). This evidence concerns the gene RASGRP4 and diabetic kidney disease.